ruthenium has been researched along with Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dixit, D; Dubey, SK; Koiri, RK; Mishra, L; Pandey, K; Trigun, SK | 1 |
Bergamo, A; Capozzi, I; Clerici, K; Cocchietto, M; Salerno, G; Sava, G | 1 |
2 other study(ies) available for ruthenium and Lymphoma
Article | Year |
---|---|
Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand.
Topics: Alanine Transaminase; Animals; Apoptosis; Ascitic Fluid; Aspartate Aminotransferases; Benzamides; Cell Death; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA Fragmentation; Isoenzymes; L-Lactate Dehydrogenase; Ligands; Lymphoma; Mice; Remission Induction; Ruthenium; Survival Analysis | 2009 |
Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Survival; Cisplatin; Dimethyl Sulfoxide; DNA, Neoplasm; Doxorubicin; Flow Cytometry; In Vitro Techniques; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Tumor Cells, Cultured | 1998 |